---
figid: PMC9117958__etm-23-06-11341-g03
pmcid: PMC9117958
image_filename: etm-23-06-11341-g03.jpg
figure_link: /pmc/articles/PMC9117958/figure/f4-ETM-0-0-11341/
number: Figure 4
figure_title: ''
caption: RV treatment promotes anti-atherosclerotic activity in atherosclerosis model
  mice. (A-F) Effects of RV treatment on (A) HMG-CoA reductase activity, (B) LDH levels,
  (C) CPK activity, (D) serum ALT levels, (E) serum AST levels and (F) serum ALP levels
  compared with the control. *P<0.05 and **P<0.01. RV, resveratrol; LDH, lactate dehydrogenase;
  CPK, creatine phosphokinase; ALT, alanine transaminase; AST, aspartate transaminase;
  ALP, alkaline phosphatase.
article_title: Resveratrol protects against atherosclerosis by downregulating the
  PI3K/AKT/mTOR signaling pathway in atherosclerosis model mice.
citation: Wuguang Ji, et al. Exp Ther Med. 2022 Jun;23(6):414.
year: '2022'

doi: 10.3892/etm.2022.11341
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- resveratrol
- atherosclerosis
- inflammation
- PI3K
- AKT
- mTOR

---
